Furthermore, the log-rank test suggested that there was a significant difference in the 1-year pneumonia-free survival rate between PC patients who did and those who did not receive treatment with GnRH agonists (p<0.002). The gene discussed is GNRH1; the disease is pachyonychia congenita.